(1)
B5H7, a Morpholine Derivative of 23-Hydroxybetulinic Acid, Reverses Doxorubicin Resistance in HepG2 ADM. J. Can. Res. Updates 2014, 3 (1),  59-66. https://doi.org/10.6000/1929-2279.2014.03.01.6.